Showing 1 - 10 of 13,518
innovation can be systematically distorted. This paper builds a simple model of endogenous technology, which generalizes existing … comparative static results and characterizes potential distortions in the direction of innovation. I show that empirical findings …
Persistent link: https://www.econbiz.de/10014226119
. While the individual effects of engaging in the listed practices on firm innovation are well-understood, the existing … sample of innovation-active firms from the German Community Innovation Survey, which includes information on the development … of standards, enhanced with information on firms' engagement in patenting and publishing. We find that 26% of innovation …
Persistent link: https://www.econbiz.de/10013266316
This paper examines the effect of foreign direct investment (FDI) on domestic innovation based on a data set covering … show that there is a negative horizontal spillover effect of FDI on domestic innovation when the intellectual property … on why developing countries should encourage FDI and strengthen the IPR regime together to enhance domestic innovation …
Persistent link: https://www.econbiz.de/10011723712
Asia, have engaged in improving their innovation capability in the economic transition. First, I measured and compared … innovation capability of both countries by using not only various input and output indicators of innovation systems but also the … how both countries developed their innovation capabilities by focusing on their transformation of the national innovation …
Persistent link: https://www.econbiz.de/10011797407
This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms' technology dimension using patent information,...
Persistent link: https://www.econbiz.de/10014468769
Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) - about 44% of the total increase in longevity … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …
Persistent link: https://www.econbiz.de/10010473542
While most economists believe that public scientific research fuels industry innovation and economic growth, systematic … size as a significant driver of drug innovation in the pharmaceutical industry, but they did not find any evidence … supporting science-driven innovation from publicly funded research. This paper uses new data on biomedical research investments …
Persistent link: https://www.econbiz.de/10009374417
an innovation rewarding institution. According to our analysis, pharma patents have constituted legal barriers to protect …
Persistent link: https://www.econbiz.de/10012604733
their innovation activities in response to the potential entry of direct competitors. We then examine a legal ruling that … firms increased their net innovation activities in response to competitive entry. These effects center on firms with … innovation by new entrants after the ruling in response to increased competition. Overall, these results are consistent with …
Persistent link: https://www.econbiz.de/10012818283
We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …
Persistent link: https://www.econbiz.de/10009571756